Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081943/ https://www.ncbi.nlm.nih.gov/pubmed/35592373 http://dx.doi.org/10.18773/austprescr.2022.021 |
_version_ | 1784703103089508352 |
---|---|
author | Coombes, Ian D Legg, Amy Patterson, Tina Kelly, Tanya Henderson, Andrew Roberts, Jason A |
author_facet | Coombes, Ian D Legg, Amy Patterson, Tina Kelly, Tanya Henderson, Andrew Roberts, Jason A |
author_sort | Coombes, Ian D |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9081943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-90819432022-05-18 Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? Coombes, Ian D Legg, Amy Patterson, Tina Kelly, Tanya Henderson, Andrew Roberts, Jason A Aust Prescr Editorial NPS MedicineWise 2022-03-24 2022-04 /pmc/articles/PMC9081943/ /pubmed/35592373 http://dx.doi.org/10.18773/austprescr.2022.021 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Editorial Coombes, Ian D Legg, Amy Patterson, Tina Kelly, Tanya Henderson, Andrew Roberts, Jason A Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title | Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title_full | Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title_fullStr | Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title_full_unstemmed | Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title_short | Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? |
title_sort | oral antivirals for mild–moderate covid-19: a panacea or a logistical and clinical conundrum? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081943/ https://www.ncbi.nlm.nih.gov/pubmed/35592373 http://dx.doi.org/10.18773/austprescr.2022.021 |
work_keys_str_mv | AT coombesiand oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum AT leggamy oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum AT pattersontina oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum AT kellytanya oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum AT hendersonandrew oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum AT robertsjasona oralantiviralsformildmoderatecovid19apanaceaoralogisticalandclinicalconundrum |